Niels Halama, MD

Department of Medical Oncology and Internal Medicine V, National Center for Tumor Diseases (NCT), University Hospital, Heidelberg, Germany, Germany

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1142 - Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET